ATE338556T1 - Dihydrotriterpene bei der behandlung von virusinfektionen, herz und kreislauf krankheiten, entzündungen, überempfindlichkeiten oder schmerzen - Google Patents

Dihydrotriterpene bei der behandlung von virusinfektionen, herz und kreislauf krankheiten, entzündungen, überempfindlichkeiten oder schmerzen

Info

Publication number
ATE338556T1
ATE338556T1 AT02715601T AT02715601T ATE338556T1 AT E338556 T1 ATE338556 T1 AT E338556T1 AT 02715601 T AT02715601 T AT 02715601T AT 02715601 T AT02715601 T AT 02715601T AT E338556 T1 ATE338556 T1 AT E338556T1
Authority
AT
Austria
Prior art keywords
hypersensitivity
triterpenes
dihydrotriterpenes
inflammation
pain
Prior art date
Application number
AT02715601T
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Bsp Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bsp Pharma filed Critical Bsp Pharma
Application granted granted Critical
Publication of ATE338556T1 publication Critical patent/ATE338556T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Birds (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02715601T 2001-01-12 2002-01-14 Dihydrotriterpene bei der behandlung von virusinfektionen, herz und kreislauf krankheiten, entzündungen, überempfindlichkeiten oder schmerzen ATE338556T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100049 2001-01-12
US26116801P 2001-01-16 2001-01-16

Publications (1)

Publication Number Publication Date
ATE338556T1 true ATE338556T1 (de) 2006-09-15

Family

ID=26068943

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02715601T ATE338556T1 (de) 2001-01-12 2002-01-14 Dihydrotriterpene bei der behandlung von virusinfektionen, herz und kreislauf krankheiten, entzündungen, überempfindlichkeiten oder schmerzen

Country Status (12)

Country Link
EP (1) EP1349553B1 (de)
JP (1) JP2004520343A (de)
CN (1) CN1520300B (de)
AT (1) ATE338556T1 (de)
AU (1) AU2002225259B2 (de)
CA (1) CA2434670C (de)
CY (1) CY1106270T1 (de)
DE (1) DE60214509T2 (de)
DK (1) DK1349553T3 (de)
ES (1) ES2272689T3 (de)
NZ (1) NZ526969A (de)
WO (1) WO2002055087A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1424073A1 (de) * 2002-11-27 2004-06-02 Loders Croklaan B.V. Antidiarrhöe - Zusammensetzungen
US7070815B2 (en) 2002-11-27 2006-07-04 Loders Croklaan Usa Llc Anti diarrhoea compositions
WO2005077377A1 (en) * 2004-02-06 2005-08-25 Regents Of The University Of Minnesota Compositions that include a triterpene and a carrier
JP4810642B2 (ja) * 2004-11-30 2011-11-09 秋田県 癌転移抑制用トリテルペン誘導体及び該トリテルペン誘導体を用いた癌転移抑制用組成物
US20100055219A1 (en) * 2006-03-15 2010-03-04 Tropical Technology Center Ltd. Antiinflammatory agent
JP5428000B2 (ja) * 2007-06-27 2014-02-26 株式会社スカイライト・バイオテック ルペオール含有医薬組成物、食品及び飼料
CN102499925B (zh) * 2011-10-21 2015-11-11 上海中医药大学 一种中性粒细胞弹性蛋白酶抑制剂
CN104107179B (zh) * 2014-06-27 2016-08-24 王英 闭花木酮Cleistanone的二乙胺衍生物在制备抗急性痛风药物中的应用
KR101672431B1 (ko) * 2015-01-06 2016-11-04 목포대학교산학협력단 동백나무 추출물을 유효성분으로 포함하는 심혈관계 질환의 예방 또는 치료용 조성물
CN106265684A (zh) * 2016-08-11 2017-01-04 江苏康缘药业股份有限公司 乙酰羽扇豆醇酯的应用
IT201600093764A1 (it) * 2016-09-19 2018-03-19 Codex V Srl Insaponificabili di lipidi naturali per l’uso nel trattamento di patologie reumatiche
WO2018082034A1 (en) * 2016-11-04 2018-05-11 Trineo Biotechnology Co., Ltd Uses of triterpenoid mixture for treating multiple sclerosis
EP3973976A4 (de) * 2019-05-22 2023-01-18 Huscion Co., Ltd. Pharmazeutische zusammensetzung mit extrakt aus camellia japonica als wirkstoff zur vorbeugung und behandlung von virusinfektionen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB932662A (en) * 1960-04-13 1963-07-31 Laroche Navarron Lab Therapeutic compositions comprising butyrospermol
CA1265785A (en) * 1984-06-04 1990-02-13 Kumi Yoshida Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them
JP2912489B2 (ja) * 1992-01-10 1999-06-28 サンスター株式会社 皮膚化粧料
CN1158566A (zh) * 1994-06-20 1997-09-03 库特·伯格 用于预防和/或治疗病毒感染和各种炎症的药物组合物及其治疗方法
WO1998032443A1 (de) * 1997-01-24 1998-07-30 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten enthaltend antitumoral, antiviral und antiparasitär wirksame ester von pentacyclischen triterpenen
FR2770400B1 (fr) * 1997-10-30 1999-12-03 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir de la fleur de l'arbre a karite ou butyrospermum parkii kotschy
PT1200106E (pt) * 1999-07-09 2003-09-30 Bsp Pharma As Composicao contendo extractos de butyrospermum parkii e utilizacao como medicamento ou suplemento dietetico

Also Published As

Publication number Publication date
DE60214509T2 (de) 2007-05-31
CA2434670C (en) 2010-05-11
NZ526969A (en) 2005-05-27
CN1520300A (zh) 2004-08-11
EP1349553A1 (de) 2003-10-08
WO2002055087B1 (en) 2002-12-27
DE60214509D1 (de) 2006-10-19
CN1520300B (zh) 2010-10-06
CY1106270T1 (el) 2011-10-12
WO2002055087A1 (en) 2002-07-18
ES2272689T3 (es) 2007-05-01
JP2004520343A (ja) 2004-07-08
EP1349553B1 (de) 2006-09-06
AU2002225259B2 (en) 2006-02-02
DK1349553T3 (da) 2007-01-08
CA2434670A1 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
Bijauliya et al. A comprehensive review on herbal cosmetics
Anuar et al. Effect of green and ripe Carica papaya epicarp extracts on wound healing and during pregnancy
Gediya et al. Herbal plants: used as a cosmetics
CY1106270T1 (el) Διυδρο-τριτepπενια στην αντιμετωπιση ιογενων μολυνσεων, καρδιαγγειακης νοσου, φλεγμονης, υπepευαισθησιας ή πονου
UA102478C2 (en) Capsule composition
Medellín-Luna et al. Medicinal plant extracts and their use as wound closure inducing agents
Patil et al. A Review of Calendula OfficinalisMagic in Science
KR20150076948A (ko) 해조류 추출물을 함유하는 화장료 조성물
Safia et al. Assessment of rose water and evaluation of antioxidant and anti-inflammatory properties of a rose water based cream formulation
CN102440927A (zh) 一种水仙花美白爽肤水化妆品
KR101954773B1 (ko) 낙엽송 부산물로부터 다량의 유효성분을 효과적으로 분리하는 정제 방법 및 이 유효성분을 함유한 조성물
EP2503998A1 (de) Dermatologische zusammensetzungen mit einem fett oer öl eines essenziellen fettsäuretrigylzerids
JP2016532724A (ja) エンブリカのオフィシナリスの種子の抽出物の医療用組成物およびその調製方法
CN105310933A (zh) 一种抗衰老美容面膜有效成分的配方
CN105919913A (zh) 一种护肤组合物及由其制备的膏状紧致霜
WO2013072852A4 (en) Stretch mark preventer
KR20200064384A (ko) 약쑥을 함유한 항산화 및 항염증 화장료 조성물
Soji-Omoniwa et al. Consumption of cod liver oil-enriched Vernonia amygdalina Leaf-based diet promoted wound healing in wound-inflicted type 2 diabetic Wistar rats
KR20190036388A (ko) 해죽순 추출물을 함유하는 화장료 조성물
Kishore et al. Coconut Palm (Cocos nucifera L.) A Natural Gift to Humans for Dental Ministration
Ibrahim et al. Ameliorative effect of Garden cress (Lepidium sativum) seeds ethanolic extract on high fat diet-prompted non-alcoholic fatty liver disease in the rat model: Impact on 3-hydroxy-3-methylglutaryl-coenzyme a reductase and vascular endothelial growth factor
US20100008886A1 (en) Application of the oil fraction obtained from sour cherry (prunus cesarus) seed kernel
Prithiviraj et al. A review on pharmacological properties of moringa oligofera
Li et al. Pharmacological activities of components contained in camellia oil and camellia oil cake and their applications in various industries
JP2006248940A (ja) 皮膚若しくは毛髪用化粧料

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1349553

Country of ref document: EP